IMPACT OF CONCOMITANT THIOPURINE ON THE EFFICACY AND SAFETY OF FILGOTINIB TREATMENT IN PATIENTS WITH ULCERATIVE COLITIS: POST HOC ANALYSIS OF THE PHASE 2B/3 SELECTION STUDY
Kenji Watanabe 1
Laurent Peyrin-Biroulet 2
Silvio Danese 3
Kahaku Emoto 4
Yasushi Fujitani 4
Franck-Olivier Le-Brun 5
Tomohiro Ueno 5
James O. Lindsay 6
Gerhard Rogler 7
Toshifumi Hibi 8
1 Center for Inflammatory Bowel Disease, Division of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan
2 University Hospital of Nancy, University of Lorraine, Nancy, France
3 IBD Center, Humanitas Research Hospital, Milan, Italy
4 Gilead Sciences K.K., Tokyo, Japan
5 Galapagos GmbH, Basel, Switzerland
6 Centre for Immunobiology, Blizard Institute, Barts and the London School of Medicine, Queen Mary University of London, London, United Kingdom
7 University Hospital of Zurich, University of Zurich, Zurich, Switzerland
8 Center for Advanced IBD Research and Treatment, Kitasato Institute Hospital, Kitasato University, Tokyo, Japan
Session
IBD (Posters)
Conference
UEG Week Vienna 2022
Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]